University of Patras
Ανοσοϊστοχημική διερεύνηση ενδοκυττάριων οδών σηματοδότησης σε καρκινώματα ενδομητρίου και μη νεοπλασματικό ενδομήτριο
Abstract
dc:descriptionBackground/Aim: The Akt/mTOR and MAPK pathways are frequently activated in various tumor types but data on endometrial carcinoma are limited. The aim of this study was to investigate the clinical significance of the expression of phosphorylated MAPK, Akt and mTOR (p-MAPK, p-Akt, p-mTOR) in type I endometrial carcinoma. Patients and Methods: The study comprised 103 formalin-fixed paraffin-embedded (FFPE) type I endometrial carcinoma cases, retrospectively retrieved and assessed by immunohistochemistry for p-MAPK, p-Akt and p-mTOR expression. The expression of the same proteins was also studied in non-neoplastic endometrial tissue adjacent to the tumor.Results: The expression patterns of these molecules differed between malignant and non-tumorous tissue specimens. The immunoreactivity for p-Akt was exclusively detected in the neoplastic tissues. Expression levels of p-MAPK were higher in tumors compared to the non-neoplastic endometrium (p<0.001), while p-mTOR was found to be over-expressed in non-neoplastic endometrium compared to the carcinomas (p=0.001). Expression of p-Akt was correlated with p-MAPK protein levels (p=0.022, r=0.229). On the other hand, no association was found with clinicopathological parameters and with disease-free (DFS) or overall survival (OS) of the patients.Conclusion: Our findings support the deregulation of the PI3K/Akt/mTOR and MAPK signaling pathways in type I endometrial carcinomas suggesting involvement of these pivotal pathways in endometrial carcinogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikolaou, Marinos
- Νικολάου, Μαρίνος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36031